Natural therapies: what the scientists say
A 200-year-old form of alternative medicine, based on the principle that substances that cause symptoms in a healthy person have the ability to treat …
Go to Source
Month: January 2015
Best and Worst Sweeteners for Weight Loss
At Everyday Health, we're getting lots of questions from readers about sugar and which type is best for people looking to lose weight and give their diet …
Go to Source
Want to Lose Weight? Experts Recommend These 10 Diets
Looking for a diet to help you reach the health resolutions you set on … how nutritious and safe it is, and whether it'll live up to those big weight loss …
Go to Source
BrainStorm Enters Into Warrant Exercise Deal For Proceeds Of About $13 Mln
Biotechnology company BrainStorm Cell Therapeutics Inc. (BCLI: Quote), said it has entered into a warrant exercise agreement with certain holders of …
Go to Source
Pomfret students take innovative lead in all-school exercise
In place of structured class time and homework, students were instead tackling one of 27 innovative exercises in learning that saw plenty of overlap …
Go to Source
Low-Carb Paleo Diet Powers Kobe Bryant, Phil Mickelson, And Los Angeles Lakers — Here's Why …
… like Kobe Bryant to golf pros like Phil Mickelson, the popular Paleo diet has become the choice for athletes seeking energy, health, and weight loss.
Go to Source
Biogen experimental drug shows evidence of optic nerve repair
(Reuters) – An experimental drug from Biogen Idec Inc showed evidence of biological repair of the optic nerve in a mid-stage study in patients with acute optic neuritis, an inflammation of the optic nerve that can lead to vision loss. The drug is also being tested in patients with multiple sclerosis, an inflammatory disease that attacks the protective covers of nerve cells. Current treatments focus on decreasing inflammation rather than regenerating cells. That study's results are due in 2016, the company said. …
Brainstorm Cell Therapeutics (BCLI) Enters 2.5M Common Warrant Exercise Agreement
Brainstorm Cell Therapeutics (NASDAQ: BCLI) announced it has entered into a Warrant Exercise Agreement with certain holders of warrants issued in …
Go to Source
BrainStorm Enters Into Warrant Exercise Agreement for Approximately $13 Million in Pr…
These holders have agreed to exercise their warrants in full (for a total of approximately 2.5 million shares of common stock) at an exercise price of …
Go to Source
Gowrie Community embarkson a 3-hr clean-up exercise
A Youth Group from the Gowrie Community in the Bongo District, called “Akamtaaba Youth,” has joined President's Mahama Campaign on Sanitation.
Go to Source
Biotechs soar in premarket; many have strong drug data
NEW YORK (Reuters) – Biotech stocks were among the biggest movers during premarket trading on Thursday, with companies making up more than half of the top 25 most active Nasdaq shares and many reporting massive gains on the back of drug study data.
Go to Source
CytRx cancer drug shows promise in mid-stage study
(Reuters) – CytRx Corp said its cancer drug was effective against a type of skin cancer in HIV+ patients, sending its shares up 13 percent before the bell. Interim data from an ongoing mid-stage study showed that the drug, aldoxorubicin, stopped tumor growth in HIV+ patients suffering from Kaposi’s Sarcoma, the company said on Thursday. The U.S. Food and Drug Administration placed a hold on enrolling new patients in all clinical trials of aldoxorubicin in November, after a patient died. (Reporting by Rosmi Shaji in Bengaluru; Editing by Simon Jennings)
Go to Source